浅析间变性脑膜瘤的治疗及预后

发布时间：2018-08-12 09:12

【摘要】：探讨颅内间变性脑膜瘤的治疗及预后分析。对笔者所在医院2010年1月~2014年1月接受颅内间变性脑膜瘤治疗的患者50例,对其临床资料进行分析,分析预后相关因素。50例患者均为颅内间变性(恶性)脑膜瘤。所有患者按照Simpson分级法评估术后肿瘤切除的程度,其中26例患者接受SimpsonⅠ级切除;24例患者接受SimpsonⅡ级、Ⅲ级切除。50例患者分为四组,其中SimpsonⅠ级切除合并放疗组13例,SimpsonⅠ级切除无放疗组13例,SimpsonⅡ级、Ⅲ级切除合并放疗组12例,SimpsonⅡ级、Ⅲ级切除无放疗组12例。SimpsonⅠ级切除合并放疗组的无进展生存期(PFS)为68个月,复发率为48%。SimpsonⅠ级切除无放疗组PFS为22个月,复发率为90%。SimpsonⅡ级、Ⅲ级切除合并放疗组PFS为23个月,复发率为87%。SimpsonⅡ级、Ⅲ级切除无放疗组PFS为12个月,复发率为92%。SimpsonⅠ级切除合并术后放疗是有效治疗颅内间变性脑膜瘤并延长生存率的有效治疗方法。
[Abstract]:To investigate the treatment and prognosis of intracranial anaplastic meningioma. From January 2010 to January 2014, 50 patients with intracranial anaplastic meningioma were treated in our hospital. The clinical data were analyzed. The prognostic factors of 50 patients were all intracranial anaplastic (malignant) meningioma. All the patients were evaluated for the degree of tumor resection according to the Simpson grading method. Among them, 26 patients received Simpson grade 鈪，

本文编号：2178607